{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-027938","form_type":"8-K","ticker":"SONM","cik":"0001178697","company_name":"DNA X, Inc.","filed_at":"2024-07-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.352610+00:00","generated_at":"2026-05-31T20:23:49.990452+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Sonim Technologies announces 1-for-10 reverse stock split to regain Nasdaq compliance","bullets":["Board approved 1-for-10 reverse stock split; effective 5:00 p.m. ET on July 17, 2024.","Common stock (SONM) to commence trading on split-adjusted basis July 18, 2024; new CUSIP 83548F 309.","No fractional shares; one full share issued in lieu of any fractional share.","Split aims to increase share price to regain compliance with Nasdaq minimum bid price requirement."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-027938","json":"https://secwatch.observer/filing/0001493152-24-027938.json","markdown":"https://secwatch.observer/filing/0001493152-24-027938.md","text":"https://secwatch.observer/filing/0001493152-24-027938.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224027938/0001493152-24-027938-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1178697/000149315224027938/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:23:49.990452+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001449794-26-000012","ticker":"EMYB","company_name":"Embassy Bancorp, Inc.","filed_at":"2026-06-01T20:37:17+00:00","headline":"Embassy Bancorp expands stock repurchase program by additional $5M","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001449794-26-000012","json":"https://secwatch.observer/filing/0001449794-26-000012.json","markdown":"https://secwatch.observer/filing/0001449794-26-000012.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1449794/000144979426000012/0001449794-26-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1449794/000144979426000012/emyb-20260601x8k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-251573","ticker":"LXU","company_name":"LSB INDUSTRIES, INC.","filed_at":"2026-06-01T20:35:16+00:00","headline":"LSB Industries accelerates Pryor, OK turnaround start to May 28, 2026","event_type":"other_material","sec_items":["8.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251573","json":"https://secwatch.observer/filing/0001193125-26-251573.json","markdown":"https://secwatch.observer/filing/0001193125-26-251573.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/60714/000119312526251573/0001193125-26-251573-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/60714/000119312526251573/lxu-20260528.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-063531","ticker":"CTXR","company_name":"Citius Pharmaceuticals, Inc.","filed_at":"2026-06-01T20:30:19+00:00","headline":"Citius Oncology reports Phase 1 combo data: 24% ORR, 33% in endometrial cancer; Phase 2 planned","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063531","json":"https://secwatch.observer/filing/0001213900-26-063531.json","markdown":"https://secwatch.observer/filing/0001213900-26-063531.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506251/000121390026063531/0001213900-26-063531-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506251/000121390026063531/ea0292904-8k_citius.htm"},"side_by_side_evidence":null},{"accession":"0001437749-26-018969","ticker":"TRLC","company_name":"TriLinc Global Impact Fund LLC","filed_at":"2026-06-01T16:43:41+00:00","headline":"TriLinc Global Impact Fund portfolio assets ~$283M as of April 30, 2026","event_type":"other_material","sec_items":["8.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018969","json":"https://secwatch.observer/filing/0001437749-26-018969.json","markdown":"https://secwatch.observer/filing/0001437749-26-018969.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1550453/000143774926018969/0001437749-26-018969-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1550453/000143774926018969/trlc20260513_8k.htm"},"side_by_side_evidence":null},{"accession":"0001129928-26-000037","ticker":"ONCY","company_name":"ONCOLYTICS BIOTECH INC","filed_at":"2026-06-01T13:06:14+00:00","headline":"Oncolytics reports positive initial preclinical data for pelareorep + RAS inhibitors; further studies planned","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.45,"calibrated_materiality_score":0.45,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001129928-26-000037","json":"https://secwatch.observer/filing/0001129928-26-000037.json","markdown":"https://secwatch.observer/filing/0001129928-26-000037.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1129928/000112992826000037/0001129928-26-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1129928/000112992826000037/oncy-20260601.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-063185","ticker":"SILO","company_name":"Silo Pharma, Inc.","filed_at":"2026-06-01T13:02:13+00:00","headline":"Silo Pharma announces 1-for-15 reverse stock split effective June 2, 2026","event_type":"other_material","sec_items":["8.01"],"materiality_score":0.45,"calibrated_materiality_score":0.45,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063185","json":"https://secwatch.observer/filing/0001213900-26-063185.json","markdown":"https://secwatch.observer/filing/0001213900-26-063185.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390026063185/0001213900-26-063185-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390026063185/ea0292702-8k_silo.htm"},"side_by_side_evidence":null},{"accession":"0001564708-26-000118","ticker":"NWSA","company_name":"NEWS CORP","filed_at":"2026-06-01T10:32:37+00:00","headline":"News Corp repurchased $2.75M in shares on May 29; $276.9M used under $1B program","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001564708-26-000118","json":"https://secwatch.observer/filing/0001564708-26-000118.json","markdown":"https://secwatch.observer/filing/0001564708-26-000118.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1564708/000156470826000118/0001564708-26-000118-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1564708/000156470826000118/nws-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-063110","ticker":"RDAC","company_name":"Rising Dragon Acquisition Corp.","filed_at":"2026-06-01T10:08:35+00:00","headline":"Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed","event_type":"other_material","sec_items":["1.01","5.03","5.07","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063110","json":"https://secwatch.observer/filing/0001213900-26-063110.json","markdown":"https://secwatch.observer/filing/0001213900-26-063110.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/0001213900-26-063110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/ea0292895-8k_rising.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}